TickerFactsScreenerDevelopers

REGENXBIO Inc. (RGNX) — Cash & Equivalents

Annual figures by fiscal year, from SEC filings.

2012: $2.17M2013: $1.12M2014: $1.12M2015: $54.12M2016: $24.84M2017: $46.66M2018: $75.56M2019: $69.51M2020: $338.43M2021: $345.21M2022: $96.95M2023: $34.52M2024: $57.53M2025: $34.47M$34.47M
2012Cash & Equivalents (USD)2025
Fiscal YearCash & EquivalentsChange YoY
2025$34.47M-40.1%
2024$57.53M+66.6%
2023$34.52M-64.4%
2022$96.95M-71.9%
2021$345.21M+2.0%
2020$338.43M+386.8%
2019$69.51M-8.0%
2018$75.56M+62.0%
2017$46.66M+87.8%
2016$24.84M-54.1%
2015$54.12M+4727.5%
2014$1.12M+0.2%
2013$1.12M-48.3%
2012$2.17M—